Nir Sassi - 10 Apr 2025 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Chief Financial Officer
Signature
/s/ Nir Sassi
Issuer symbol
INDP
Transactions as of
10 Apr 2025
Net transactions value
-$500
Form type
4
Filing time
11 Apr 2025, 16:15:25 UTC
Previous filing
10 Oct 2024
Next filing
29 Dec 2025
SEC
View on sec.gov

Quoteable Key Fact

"Nir Sassi filed Form 4 for Indaptus Therapeutics, Inc. (INDP) on 11 Apr 2025."

Quick Takeaways

  • This page summarizes Nir Sassi's Form 4 filing for Indaptus Therapeutics, Inc. (INDP).
  • 7 reported transactions and 7 derivative rows are listed below.
  • Filing timestamp: 11 Apr 2025, 16:15.

What Changed

  • Previous filing in this sequence was filed on 10 Oct 2024.
  • Current net transaction value: -$500.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

INDP transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$88.75
Shares
-1,250
Change %
-100%
Price
$0.0710
Shares after
0
Date
10 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,250
Exercise price
$25.72
Footnotes
F1
INDP transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$79.88
Shares
-1,125
Change %
-100%
Price
$0.0710
Shares after
0
Date
10 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,125
Exercise price
$34.32
Footnotes
F1
INDP transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$178
Shares
-2,500
Change %
-100%
Price
$0.0710
Shares after
0
Date
10 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,500
Exercise price
$72.00
Footnotes
F1
INDP transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$35.5
Shares
-500
Change %
-100%
Price
$0.0710
Shares after
0
Date
10 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
500
Exercise price
$357.28
Footnotes
F1
INDP transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$35.5
Shares
-500
Change %
-100%
Price
$0.0710
Shares after
0
Date
10 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
500
Exercise price
$357.28
Footnotes
F1
INDP transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$2.91
Shares
-41
Change %
-100%
Price
$0.0710
Shares after
0
Date
10 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
41
Exercise price
$331.20
Footnotes
F1
INDP transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$79.88
Shares
-1,125
Change %
-100%
Price
$0.0710
Shares after
0
Date
10 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,125
Exercise price
$610.24
Footnotes
F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .